We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
94 hedge funds and large institutions have $209M invested in Sorrento Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
81% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 26
73% more capital invested
Capital invested by funds: $121M → $209M (+$88.5M)
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
29% more funds holding
Funds holding: 73 → 94 (+21)
47% less call options, than puts
Call options by funds: $3.77M | Put options by funds: $7.05M
Holders
94
Holders Change
+21
Holders Change %
+28.77%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
47
Increased
22
Reduced
13
Closed
26
Calls
$3.77M
Puts
$7.05M
Net Calls
-$3.29M
Net Calls Change
-$2.66M
Top Buyers
| 1 |
BlackRock
New York
|
+$26.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.95M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.77M |
| 5 |
Morgan Stanley
New York
|
+$2.39M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$7.96M |
| 2 |
Man Group
London,
United Kingdom
|
-$6.91M |
| 3 |
IP
Intellectus Partners
San Francisco,
California
|
-$5.42M |
| 4 |
Renaissance Technologies
New York
|
-$3.71M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.21M |
